StockData
Ginkgo Bioworks Holdings, Inc. logo

Ginkgo Bioworks Holdings, Inc. (DNA) stock

DNANYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3013% below fair value
$8.32−0.18 (-2.12%)

Close on Nov 17, 2026Market cap $560.27MP/E –Yield –

Ginkgo Bioworks price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Ginkgo Bioworks's price to sales ratio was 4.9× on Nov 11, 2026, against 3.5× a year earlier. Over the last 5 years it ranged from 1.4× to 62.6×, with a median of 5.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.9×+1.8
2025Dec 31, 20253.1×+0.7
2024Dec 31, 20242.4×−8.2
2023Dec 29, 202310.6×+5.3
2022Dec 30, 20225.3×−57.3
2021Dec 31, 202162.6×–

More Ginkgo Bioworks figures

See a number that looks wrong?